STOCK TITAN

COHEN & STEERS, INC. SEC Filings

CNS NYSE

Welcome to our dedicated page for COHEN & STEERS SEC filings (Ticker: CNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Cohen & Steers, Inc. filings document the public-company disclosures of an asset manager whose common stock trades on the New York Stock Exchange under CNS. Recent Form 8-K reports cover quarterly and annual results, annual meeting voting outcomes, executive-officer changes and material agreements, including amendments to a senior unsecured revolving credit facility.

Proxy materials describe board elections, auditor ratification, advisory executive-compensation votes and governance practices. The filings also provide formal records of operating results, compensation disclosures, capital and liquidity arrangements and shareholder voting mechanics for the company's investment-management business.

Rhea-AI Summary

Cohen & Steers, Inc. (CNS) — Form 4 insider activity: Executive Chairman, Director, and 10% owner Robert H. Steers reported a series of open‑market purchases (code P) of CNS common stock on 11/03/2025, 11/04/2025, and 11/05/2025 at weighted average prices listed in the filing.

Through the Robert H. Steers 2018 Revocable Trust, purchases included 19,856 shares at $68.15, 1,294 at $68.66, 27,292 at $67.95, 642 at $68.39, and 19,329 at $67.61, with beneficial ownership shown as 7,128,497 shares following the last reported transaction. The Hilltop GST Non‑Exempt Descendants' Trust reported 17,200 shares at $68.21, 300 at $68.65, and 14,975 at $67.96, with 3,891,184 shares owned following the last entry.

Additional reported holdings include 805,920 shares by The Sunnyridge GST Exempt Family Trust, 334 shares by the Hamilton‑Steers 2017 Trust FB Robert H. Steers, and 139,747 shares held directly. Footnotes state Mr. Steers disclaims beneficial ownership of certain trust‑held shares except to the extent of his pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cohen & Steers (CNS) reported Q3 2025 results with revenue of $141.7 million, up 6.4% year over year, and diluted EPS of $0.81 versus $0.77. Operating income rose to $48.9 million and the operating margin improved to 34.5% from 33.7%.

Total assets under management were $90.9 billion, down 1.0% from a year ago. Open-end funds averaged higher assets and fees, driving advisory and administration fees to $133.6 million (up 6.6%). Distribution and service fees were $7.5 million. Expenses increased 5.1% to $92.8 million, led by distribution, service, and general and administrative costs.

Cash and cash equivalents were $98.1 million as of September 30, 2025. The company amended its revolving credit facility to $100.0 million maturing August 15, 2029. Subsequent events included a closed-end fund rights offering that raised approximately $353.2 million in proceeds (fund level) and a declared quarterly dividend of $0.62 per share payable November 20, 2025 to holders of record on November 10, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Cohen & Steers (CNS): Executive Chairman and 10% owner Robert H. Steers reported multiple open‑market purchases of common stock on Oct 20–22, 2025, primarily through family trusts. Examples include the Robert H. Steers 2018 Revocable Trust buying 6,382 shares at a $69.50 weighted average and 5,557 shares at $71.30. The Hilltop GST Non‑Exempt Descendants' Trust reported buys such as 5,204 shares at $69.44 and 5,434 shares at $71.31. Post‑trade, indirect holdings shown include 7,060,084 shares (Revocable Trust) and 3,858,709 shares (Hilltop Trust).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Cohen & Steers, Inc. (CNS) insider transaction: The company’s Interim CFO and SVP reported an acquisition of 2,154 shares of common stock on 10/17/2025 at a reported price of $0, tied to a grant of restricted stock units (RSUs). Following the transaction, the reporting person beneficially owns 26,018 shares directly.

The RSUs vest ratably over four years. Any dividends paid on the common stock are paid as additional RSUs, and those dividend RSUs vest on the fourth anniversary of the original RSU grant date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cohen & Steers, Inc. (CNS) filed a Form 3 reporting its Interim CFO and SVP’s beneficial ownership. The officer directly owns 23,864 shares of common stock. This amount includes 17,604 restricted stock units previously granted. The filing is tied to the event date 10/17/2025, and ownership is reported as direct.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cohen & Steers, Inc. furnished an 8-K announcing the availability of its results for the quarter ended September 30, 2025. The company provided an earnings announcement (Exhibit 99.1) and a full earnings release (Exhibit 99.2).

The Item 2.02 information, including the exhibits, is being furnished—not filed—under the Exchange Act.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.81%
Tags
current report
Rhea-AI Summary

Reena Aggarwal, a director of Cohen & Steers, Inc. (CNS), reported a stock award transaction dated 10/01/2025. The filing shows acquisition of 423 shares of common stock resulting from restricted stock units granted by the issuer at a $0 per-share price, and the reporting person holds 16,185 shares following the transaction. The RSUs were 100% vested on the grant date, with the underlying shares to be delivered on the third anniversary of the grant date. The Form 4 was filed by one reporting person and signed on behalf of the reporting person by an attorney-in-fact on 10/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Edmond D. Villani, a director of Cohen & Steers, Inc. (CNS), reported multiple equity transactions in early October 2025. On 10/01/2025 he was granted 423 restricted stock units that were 100% vested on the grant date and will be delivered on the third anniversary of the grant. On 10/03/2025 he reported transferring 4,589 shares to the Edmond Dennis Villani Revocable Trust and also a reportable acquisition showing the trust holds 30,259 shares. Following the transactions, Dr. Villani directly owned 5,021 shares and the trust held the stated indirect position. The filings were signed by an attorney-in-fact on 10/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Connor Frank T, a director of Cohen & Steers, Inc. (CNS), reported a grant of 423 restricted stock units on 10/01/2025 that were 100% vested on the grant date. The Form 4 shows the RSUs were granted with a $0 price and that the related 423 shares will be delivered to the reporting person on the third anniversary of the grant date. After the reported transaction, the reporting person beneficially owns 23,155 shares of common stock. The filing was signed by an attorney-in-fact on 10/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Martin Cohen, a Director and 10% owner of Cohen & Steers, Inc. (CNS), filed a Form 4 reporting changes in his beneficial ownership. The filing shows 8,171,461 shares of common stock held indirectly by the Martin Cohen 2018 Revocable Trust, of which Mr. Cohen disclaims beneficial ownership except to the extent of his pecuniary interest. On 10/01/2025 the filing records a transaction coded A for 423 restricted stock units (RSUs) granted at a $0 price; the RSUs are stated to be 100% vested on the grant date and will be delivered on the third anniversary of the grant date. The Form 4 also reports a disposition of 849,205 shares. The filing is signed by an attorney-in-fact on 10/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many COHEN & STEERS (CNS) SEC filings are available on StockTitan?

StockTitan tracks 113 SEC filings for COHEN & STEERS (CNS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for COHEN & STEERS (CNS)?

The most recent SEC filing for COHEN & STEERS (CNS) was filed on November 5, 2025.